ARTICLE | Company News
BioLineRx, Genoscience deal
January 30, 2012 8:00 AM UTC
Genoscience granted BioLineRx exclusive, worldwide rights to preclinical oral HCV compound BL-8020. BioLineRx received an upfront payment and is eligible for milestones plus royalties. Details were n...